Antiviral Drugs Market Trends

Growth Drivers

• Rising Geriatric Population – The rising number of old people across the world and their rising high chances of getting viral infections is estimated to boost the market growth during the forecast period. Old people are susceptible to diseases due to less immune strength which makes them more prone to any disease or infection. As per the World Health Organization, the number of people aged 60 years and above rose from 1 billion in 2020 to 1.4 billion in 2022.

• Increased Cases of COVID – 19 – The number of global COVID cases across the world in 2022 was 625,700,400 as per the estimations.

• Rising Risk of STDs Among Adults – According to the observations, over 1 million sexually transmitted diseases occur each year with an estimated more than 350 new infections.

• Growing Demand for Generic Versions – As per the IMS Health Institute, the healthcare system of the U.S saved USD 2.2 trillion between 2009 to 2019 with the use of generic drugs.

• Rising Vaccinations Against Viral Infections – The COVID-19 vaccine was administered in more than 13 billion doses until 2022.

Challenges

• Increasing Awareness About Preventive Drugs Treatment
• Presence of Generics
• Drug Resistance

The global antiviral drugs market is segmented and analyzed for demand and supply by drug class into DNA polymerases, reverse transcription, protease, and neuraminidase inhibitors. Out of these, reverse transcription is anticipated to hold the largest market size by the end of 2033 on the back of the growing diagnosis and treatment rate of HIV infection and the increasing efficiency of antiviral drugs on viral diseases. In 2021, about 29 million individuals who suffered from HIV received antiretroviral therapy.